HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nov. 18, 2005--Cholesterol-lowering drugs like statins were found to slow the progression of Alzheimer’s disease (AD) in a new three year study of 342 AD patients (J. Neurol. Neurosurg. Psychiatry December, 2005; 76:1624-1629). Researchers at the University of Lille and the University Hospital, Lille, France compared AD patients taking cholesterol-lowering medication including statins to AD patients with unmedicated high cholesterol levels and to AD patients with normal cholesterol. They found that the use of cholesterol-lowering medication significantly slowed the cognitive decline that is the hallmark of AD as compared to both the unmedicated high cholesterol group and the normal cholesterol group.
